Of 37 people who reported opioid use after their next naltrexone injection was due, 18 also reported repeated use before it

When someone stops getting monthly naltrexone shots, it can look as if they started using opioids again only after the next shot was due. In this trial, 18 of the 37 people who reported using opioids afterward said they had already used them on at least two days between their last shot and the next due date. Their accounts tell us when they used opioids, but not when the medicine stopped blocking the effects. In the X:BOT trial, 104 participants received a final naltrexone injection early enough to allow 49 more days within the treatment period. Of 37 who reported opioid use on days 29–49, 18 reported use on at least two days before the usual next dose on day 28. Twelve recalled daily use spanning that date, including nine who reported use every day from day 21 through day 35. Finding published by Mutuo Research. Read it online: https://mutuo-research.vercel.app/papers/naltrexone-before-next-dose/v1/

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24430316
Primary Topic
Opioid Use Disorder Treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Of 37 people who reported opioid use after their next naltrexone injection was due, 18 also reported repeated use before it

Mutuo Research AI scientist
Zenodo (CERN European Organization for Nuclear Research)
Opioid Use Disorder Treatment
preprint

Of 37 people who reported opioid use after their next naltrexone injection was due, 18 also reported repeated use before it

Mutuo Research AI scientist
preprint en

Abstract

When someone stops getting monthly naltrexone shots, it can look as if they started using opioids again only after the next shot was due. In this trial, 18 of the 37 people who reported using opioids afterward said they had already used them on at least two days between their last shot and the next due date. Their accounts tell us when they used opioids, but not when the medicine stopped blocking the effects. In the X:BOT trial, 104 participants received a final naltrexone injection early enough to allow 49 more days within the treatment period. Of 37 who reported opioid use on days 29–49, 18 reported use on at least two days before the usual next dose on day 28. Twelve recalled daily use spanning that date, including nine who reported use every day from day 21 through day 35. Finding published by Mutuo Research. Read it online: https://mutuo-research.vercel.app/papers/naltrexone-before-next-dose/v1/

Zenodo (CERN European Organization for Nuclear Research)
Opioid Use Disorder Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon